Marksans Pharma Ltd. - MARKSANS, 524404 corporate action history

Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404

Mid-range Performer

Download real time

255.15 -6.27 (-2.40%)

28.87% Fall from 52W High

820.1K NSE+BSE Volume

NSE 02 Jun, 2025 3:31 PM (IST)

11,562.5

Market Cap

High in industry

1.3

Beta 1Year

Very High Volatility

Marksans Pharma Ltd. Bonus history

Marksans Pharma Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Split history for Marksans Pharma Ltd.

Marksans Pharma Ltd. has split the face value 1 time since March 11, 2008. Marksans Pharma Ltd. had last split the face value of its shares from ₹10 to ₹1 in 2008.The share has been quoting on an ex-split basis from March 11, 2008.

Ex-Date	Old FV	New FV	Record Date
11 Mar 2008	10	1	-

See all forthcoming Bonus and split

Dividend history for Marksans Pharma Ltd.

Marksans Pharma Ltd. has declared 11 dividends since Sept. 18, 2014.

In the past 12 months, Marksans Pharma Ltd. has declared an equity dividend amounting to ₹0.60 per share.

At the current share price of ₹255.1500, Marksans Pharma Ltd.'s dividend yield is 0.24%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
17 Sep 2024	0.60	FINAL	17 Sep 2024	Equity Share
07 Jun 2023	0.50	FINAL	07 Jun 2023	Equity Share
19 Aug 2022	0.25	FINAL	-	Equity Share
15 Sep 2021	0.25	FINAL	-	Equity Share
22 Sep 2020	0.10	FINAL	-	Equity Share
19 Sep 2019	0.05	FINAL	-	Equity Share
19 Sep 2018	0.05	FINAL	-	Equity Share
19 Sep 2017	0.05	FINAL	-	Equity Share
22 Sep 2016	0.12	FINAL	-	Equity Share
23 Sep 2015	0.12	FINAL	-	Equity Share
18 Sep 2014	0.10	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Marksans Pharma Ltd.

The latest board meeting for Marksans Pharma Ltd. took place on 19 May 2025, for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
19 May 2025	Audited Results & Final Dividend	-
11 Feb 2025	Quarterly Results	-
12 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
30 May 2024	Audited Results & Final Dividend	-
13 Feb 2024	Quarterly Results	-
09 Nov 2023	Quarterly Results	-
11 Aug 2023	Quarterly Results	-
30 May 2023	Audited Results & Final Dividend	-
13 Feb 2023	Quarterly Results	-

See all Board Meetings for Marksans Pharma Ltd.

Marksans Pharma Ltd. Rights history

Marksans Pharma Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Marksans Pharma Ltd.

Is Marksans Pharma Ltd. worth buying?

1395 Votes:

Buy 80.5%

Sell 10.11%

Hold 9.39%